Here are three quick points:
1. Analysts expected second quarter revenue of $21.59 million.
2. Most recently, CEO Daniel S. Goldberger bought 5,000 company shares, at $2.34 per share, on May 10, 2016.
3. Director Kent L. Swanson purchased 3,300 shares, at $2.83 per share, on Dec. 3, 2015.
More articles on devices:
Camber Spine Technologies, Dr. Joseph DiCicco to study SI joint implant Prolix: 5 key notes
Orthopedic, spine device company mergers, acquisitions & partnerships: 8 recent deals
Stryker Performance Solutions launches Episode Performance Manager for TJR procedures: 6 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
